Abstract
Bieck, Peter R., Karl-Heinz Antonin, Richard Balon and Gregory Oxenkrug: Effect of brofaromine and pargyline on human plasma melatonin concentrations. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1988, 12 : 93–101. 1. 1. Plasma melatonin was used to determine the influence of two monoamine oxidase inhibitor drugs in 11 normal subjects. 2. 2. Acute oral administration of the selective reversible MAO-A inhibitor brofaromine but not of the — in low doses — selective MAO-B inhibitor pargyline increased daytime melatonin with large variations in onset, degree and duration. 3. 3. Further investigation of this selective action on melatonin might help to better understand the action of the therapeutically effective antidepressive therapy with selective MAO-A inhibitors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Progress in Neuropsychopharmacology & Biological Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
